Table 2.
Metabolite | Superpathway | Subpathway | Mean differencea) | p‐value |
---|---|---|---|---|
Hydroxyasparagine | Amino acid | Alanine and aspartate metabolism | –0.0690 | 1.85 × 10−7 |
Creatine | Amino acid | Creatine metabolism | 0.1189 | 2.23 × 10−6 |
Pyroglutamine* | Amino acid | Glutamate metabolism | −0.1294 | 4.88 × 10−5 |
N‐acetylglycine | Amino acid | Glycine, serine and threonine metabolism | 0.1827 | 3.62 × 10−7 |
Glycine | Amino acid | Glycine, serine and threonine metabolism | –0.0548 | 2.35 × 10−5 |
Betaine | Amino acid | Glycine, serine and threonine metabolism | –0.0514 | 1.72 × 10−5 |
Guanidinosuccinate | Amino acid | Guanidino and acetamido metabolism | 0.3052 | 4.47 × 10−12 |
1‐methyl‐5‐imidazoleacetate | Amino acid | Histidine metabolism | 0.2676 | 2.00 × 10−6 |
hydantoin‐5‐propionate | Amino acid | Histidine metabolism | 0.1899 | 2.05 × 10−5 |
1‐ribosyl‐imidazoleacetate* | Amino acid | Histidine metabolism | −0.0670 | 4.87 × 10−5 |
Tiglyl carnitine (C5) | Amino acid | Leucine, isoleucine and valine metabolism | 0.3195 | 1.93 × 10−16 |
Isobutyrylcarnitine (C4) | Amino acid | Leucine, isoleucine and valine metabolism | 0.2009 | 2.44 × 10−8 |
3‐hydroxyisobutyrate | Amino acid | Leucine, isoleucine and valine metabolism | 0.1937 | 2.42 × 10−6 |
3‐methylglutaconate | Amino acid | Leucine, isoleucine and valine metabolism | 0.1570 | 8.21 × 10−8 |
N,N,N‐trimethyl‐5‐aminovalerate | Amino acid | Lysine metabolism | −0.1228 | 4.34 × 10−12 |
S‐methylcysteine | Amino acid | Methionine, cysteine, SAM and taurine metabolism | −0.1868 | 4.44 × 10−7 |
Phenylacetate | Amino acid | Phenylalanine metabolism | 0.2406 | 3.27 × 10−5 |
2‐hydroxyphenylacetate | Amino acid | Phenylalanine metabolism | 0.2030 | 9.48 × 10−7 |
Tryptophan betaine | Amino acid | Tryptophan metabolism | 0.5422 | 2.91 × 10−25 |
Indolepropionate | Amino acid | Tryptophan metabolism | −0.3145 | 1.24 × 10−8 |
Xanthurenate | Amino acid | Tryptophan metabolism | 0.2351 | 7.98 × 10−6 |
N‐formylanthranilic acid | Amino acid | Tryptophan metabolism | 0.2310 | 2.06 × 10−7 |
3‐indoxyl sulfate | Amino acid | Tryptophan metabolism | 0.1916 | 2.92 × 10−5 |
6‐bromotryptophan | Amino acid | Tryptophan metabolism | −0.0944 | 9.46 × 10−9 |
3‐methoxytyrosine | Amino acid | Tyrosine metabolism | −0.0975 | 2.54 × 10−5 |
Urea | Amino acid | Urea cycle; arginine and proline metabolism | 0.2094 | 1.19 × 10−19 |
Argininate* | Amino acid | Urea cycle; arginine and proline metabolism | 0.2048 | 6.57 × 10−7 |
Glycerate | Carbohydrate | Glycolysis, gluconeogenesis, and pyruvate metabolism | −0.0781 | 5.50 × 10−7 |
Ribulonate/xylulonate/lyxonate* | Carbohydrate | Pentose metabolism | –0.1664 | 3.71 × 10−9 |
Arabonate/xylonate | Carbohydrate | Pentose Metabolism | –0.1121 | 5.32 × 10−5 |
Oxalate (ethanedioate) | Cofactors and vitamins | Ascorbate and aldarate metabolism | –0.1075 | 1.20 × 10−8 |
N1‐Methyl‐2‐pyridone‐5‐carboxamide | Cofactors and vitamins | Nicotinate and nicotinamide metabolism | 0.1493 | 9.76 × 10−6 |
Gamma‐CEHC glucuronide* | Cofactors and vitamins | Tocopherol metabolism | −0.3241 | 5.09 × 10−7 |
Gamma‐CEHC | Cofactors and vitamins | Tocopherol metabolism | −0.3051 | 6.59 × 10−13 |
delta‐CEHC | Cofactors and vitamins | Tocopherol metabolism | –0.2690 | 2.23 × 10−6 |
Pyridoxate | Cofactors and vitamins | Vitamin B6 metabolism | 0.1542 | 8.98 × 10−7 |
Succinylcarnitine (C4) | Energy | TCA Cycle | −0.0982 | 2.93 × 10−5 |
5alpha‐androstan‐3alpha,17beta‐diol monosulfate (1) | Lipid | Androgenic steroids | −0.1710 | 3.28 × 10−6 |
Androstenediol (3beta,17beta) monosulfate (2) | Lipid | Androgenic steroids | −0.1573 | 1.43 × 10−9 |
5alpha‐androstan‐3beta,17beta‐diol disulfate | Lipid | Androgenic steroids | −0.1544 | 4.85 × 10−6 |
Androsterone sulfate | Lipid | Androgenic steroids | −0.1344 | 1.86 × 10−7 |
Androstenediol (3beta,17beta) disulfate (1) | Lipid | Androgenic steroids | −0.1300 | 2.47 × 10−7 |
Androstenediol (3alpha, 17alpha) monosulfate (3) | Lipid | Androgenic steroids | −0.1002 | 2.21 × 10−5 |
N‐stearoyl‐sphingosine (d18:1/18:0)* | Lipid | Ceramides | −0.1253 | 2.47 × 10−7 |
Ceramide (d18:2/24:1, d18:1/24:2)* | Lipid | Ceramides | −0.1212 | 2.00 × 10−5 |
3,4‐methyleneheptanoylcarnitine | Lipid | Fatty acid metabolism(Acyl Carnitine) | −0.3080 | 8.90 × 10−8 |
Lignoceroylcarnitine (C24)* | Lipid | Fatty acid Metabolism(Acyl Carnitine) | 0.1494 | 1.31 × 10−6 |
Picolinoylglycine | Lipid | Fatty acid metabolism(Acyl Glycine) | 0.2212 | 4.83 × 10−9 |
16‐hydroxypalmitate | Lipid | Fatty acid, monohydroxy | −0.1073 | 5.88 × 10−5 |
Glycosyl‐N‐(2‐hydroxynervonoyl)‐sphingosine (d18:1/24:1(2OH))* | Lipid | Hexosylceramides (HCER) | −0.3066 | 8.55 × 10−8 |
Glycosyl‐N‐nervonoyl‐sphingosine (d18:1/24:1)* | Lipid | Hexosylceramides (HCER) | –0.1456 | 5.65 × 10−10 |
Glycosyl ceramide (d18:2/24:1, d18:1/24:2)* | Lipid | Hexosylceramides (HCER) | −0.1416 | 2.96 × 10−8 |
Glycosyl‐N‐stearoyl‐sphingosine (d18:1/18:0) | Lipid | Hexosylceramides (HCER) | −0.1408 | 4.08 × 10−8 |
Glycosyl‐N‐palmitoyl‐sphingosine (d18:1/16:0) | Lipid | Hexosylceramides (HCER) | −0.0670 | 2.62 × 10−5 |
1‐linolenoyl‐GPC (18:3)* | Lipid | Lysophospholipid | −0.2207 | 5.66 × 10−9 |
1‐linoleoyl‐GPE (18:2)* | Lipid | Lysophospholipid | −0.1425 | 5.28 × 10−6 |
1‐stearoyl‐2‐docosahexaenoyl‐GPC (18:0/22:6) | Lipid | Phosphatidylcholine (PC) | −0.1268 | 1.72 × 10−12 |
1‐stearoyl‐2‐oleoyl‐GPC (18:0/18:1) | Lipid | Phosphatidylcholine (PC) | −0.1148 | 2.86 × 10−7 |
1‐palmitoyl‐2‐stearoyl‐GPC (16:0/18:0) | Lipid | Phosphatidylcholine (PC) | −0.0751 | 2.81 × 10−6 |
1‐palmitoyl‐2‐oleoyl‐GPC (16:0/18:1) | Lipid | Phosphatidylcholine (PC) | −0.0648 | 5.03 × 10−5 |
1‐palmitoyl‐2‐arachidonoyl‐GPI (16:0/20:4)* | Lipid | Phosphatidylinositol (PI) | −0.1552 | 7.81 × 10−6 |
1‐palmitoyl‐2‐linoleoyl‐GPI (16:0/18:2) | Lipid | Phosphatidylinositol (PI) | −0.1434 | 4.46 × 10−6 |
1‐(1‐enyl‐palmitoyl)‐2‐arachidonoyl‐GPE (P‐16:0/20:4)* | Lipid | Plasmalogen | 0.1394 | 4.66 × 10−8 |
1‐(1‐enyl‐stearoyl)‐2‐arachidonoyl‐GPE (P‐18:0/20:4)* | Lipid | Plasmalogen | 0.0980 | 1.19 × 10−5 |
1‐(1‐enyl‐palmitoyl)‐2‐arachidonoyl‐GPC (P‐16:0/20:4)* | Lipid | Plasmalogen | 0.0901 | 3.29 × 10−8 |
Sphingomyelin (d18:2/14:0, d18:1/14:1)* | Lipid | Sphingomyelins | −0.0971 | 1.04 × 10−7 |
Sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* | Lipid | Sphingomyelins | 0.0873 | 2.02 × 10−6 |
Sphingomyelin (d18:2/23:1)* | Lipid | Sphingomyelins | −0.0859 | 7.32 × 10−6 |
Sphingomyelin (d17:1/14:0, d16:1/15:0)* | Lipid | Sphingomyelins | −0.0802 | 3.04 × 10−5 |
Sphingomyelin (d18:2/24:2)* | Lipid | Sphingomyelins | −0.0753 | 2.77 × 10−6 |
Stearoyl sphingomyelin (d18:1/18:0) | Lipid | Sphingomyelins | −0.0665 | 1.24 × 10−5 |
Sphingomyelin (d18:2/24:1, d18:1/24:2)* | Lipid | Sphingomyelins | −0.0664 | 3.51 × 10−6 |
Uracil | Nucleotide | Pyrimidine metabolism, uracil containing | 0.2314 | 1.22 × 10−7 |
Uridine | Nucleotide | Pyrimidine metabolism, uracil containing | 0.0832 | 3.88 × 10−6 |
Glycine conjugate of C10H14O2 (1)* | Partially characterized molecules | Partially characterized molecules | −0.2161 | 1.96 × 10−5 |
Metabolonic lactone sulfate | Partially characterized molecules | Partially characterized molecules | −0.2154 | 4.37 × 10−18 |
Phenylacetylglutamate | Peptide | Acetylated peptides | 0.3346 | 3.26 × 10−5 |
Phenylacetylglutamine | Peptide | Acetylated peptides | 0.2313 | 1.07 × 10−5 |
1H‐indole‐7‐acetic acid | Xenobiotics | Bacterial/fungal | 0.4521 | 1.46 × 10−6 |
4‐ethylphenyl sulfate | Xenobiotics | Benzoate metabolism | 1.2830 | 8.94 × 10−22 |
4‐acetylphenyl sulfate | Xenobiotics | Benzoate metabolism | 0.6736 | 1.63 × 10−12 |
Hippurate | Xenobiotics | Benzoate metabolism | −0.5706 | 4.07 × 10−11 |
4‐vinylphenol sulfate | Xenobiotics | Benzoate metabolism | 0.4873 | 2.29 × 10−7 |
Guaiacol sulfate | Xenobiotics | Benzoate metabolism | −0.3593 | 5.86 × 10−8 |
Catechol sulfate | Xenobiotics | Benzoate metabolism | −0.3333 | 3.54 × 10−8 |
Benzoylcarnitine* | Xenobiotics | Chemical | −0.6127 | 6.89 × 10−16 |
Indoleacetylcarnitine* | Xenobiotics | Chemical | 0.3876 | 6.43 × 10−9 |
6‐hydroxyindole sulfate | Xenobiotics | Chemical | 0.2068 | 3.26 × 10−5 |
Quinate | Xenobiotics | Food component/Plant | −1.0307 | 2.35 × 10−15 |
Piperine | Xenobiotics | Food component/Plant | 0.8829 | 8.53 × 10−14 |
Sulfate of piperine metabolite C18H21NO3 (1)* | Xenobiotics | Food component/Plant | 0.7956 | 1.90 × 10−19 |
Sulfate of piperine metabolite C16H19NO3 (3)* | Xenobiotics | Food component/Plant | 0.7655 | 9.00 × 10−15 |
Sulfate of piperine metabolite C16H19NO3 (2)* | Xenobiotics | Food component/Plant | 0.7431 | 1.48 × 10−15 |
Sulfate of piperine metabolite C18H21NO3 (3)* | Xenobiotics | Food component/Plant | 0.6537 | 1.33 × 10−18 |
Glucuronide of piperine metabolite C17H21NO3 (4)* | Xenobiotics | Food component/Plant | 0.6100 | 3.52 × 10−10 |
Glucuronide of piperine metabolite C17H21NO3 (3)* | Xenobiotics | Food component/Plant | 0.5843 | 4.53 × 10−10 |
Genistein sulfate* | Xenobiotics | Food component/Plant | 0.5504 | 3.38 × 10−8 |
Glucuronide of piperine metabolite C17H21NO3 (5)* | Xenobiotics | Food component/Plant | 0.4446 | 6.10 × 10−8 |
Pyrraline | Xenobiotics | Food component/Plant | 0.3915 | 5.20 × 10−7 |
Stachydrine | Xenobiotics | Food component/Plant | −0.3181 | 5.99 × 10−11 |
3,4‐methyleneheptanoate | Xenobiotics | Food component/Plant | −0.3098 | 2.89 × 10−5 |
homostachydrine* | Xenobiotics | Food component/Plant | −0.2137 | 1.22 × 10−8 |
Mean difference represents differences in plasma levels comparing the protein‐rich dietary pattern versus the carbohydrate‐rich dietary pattern at the end of the 6‐week intervention. Positive mean difference indicates that the metabolite was higher after the protein‐rich relative to the carbohydrate‐rich dietary patterns. Negative mean difference indicates that the metabolite was higher after the carbohydrate‐rich relative to the protein‐rich dietary patterns. Only metabolites which passed the Bonferroni threshold are presented (0.05/839 = 5.95 × 10−5). p value is derived from paired t‐test.
Asterisk indicates metabolites not officially confirmed (tier 2 identification).